DocumentsDate added
Case report:-
T Mathew * *School Of Dentistry, International Medical University, Bukit Jalil, Kuala Lumpur , Malaysia, 57000.
Abstract:- Introduction: Functional appliance is an effective way of treating skeletal Class II malocclusion in children and adolescents. A 12-month mandibular advancement protocol with Twin Block appliance has been proved to enhance the condylar growth and to improve the mandibular retrognathism. Objective: The case report documented the treatment of a 12- year- old girl with skeletal class II malocclusion with over jet of 8mm, 100% Deep bite and Angle Class II molar, Class II canine and Class II incisor relationship. Method: The phase I Orthopedic stage treatment was done using Twin Block appliance for 12 months with mandibular advancement of 8mm including trimming of inter-occlusal bite plane of the Twin Block to facilitate the eruption of Mandibular molars. This was followed by a phase II Pre-adjusted Edgewise appliance therapy for finishing and detailing. Result: The treatment objective of normal overjet and overbite, skeletal class I by growth modification, class I molar relation, class I canine relation, class I incisor relation and lip competency were achieved. Conclusion: A stable harmonious occlusion was achieved after 20 months of treatment.
Key Words:- Functional appliances. Angle Class II malocclusion. Pre-adjusted Edgewise appliance.
References:-
1. McÑamara J A. Components of Class II malocclusion in children 8-10 years of age. Angle Orthod. 1981; 51:177-202.
2. Graber T M, Rakosi T, Petrovic A. Dento-facial Orthopedics with Functional Appliances. St Louis, Mo: Mosby; 1997:346-52.
3. Hägg U, Taranger J. Maturation indicators and the pubertal growth spurt. Am J Orthod. 1982;82(4):299-309.
4. Baccetti T, Franchi L, James A, McNamara JA Jr. The cervical vertebral maturation (CVM) method for assessment of optimal treatment timing in dentofacial orthopaedic. Semin Orthod. 2004;11:119-29.
5. Khal HA, Wong RW, Rabie AB. Elimination of hand-wrist radiographs for maturity assessment in children needing orthodontic therapy. Skeletal Radiol. 2008;37(3):195-200. Epub 2007 Oct 3.
6. Hägg U, Pancherz H. Dentofacial orthopaedics in relation to chronological age, growth period and skeletal development. An analysis of 72 male patients with Class II division 1 malocclusion treated with the Herbst appliance. Eur J Orthod. 1988;10(1):169-76.
7. Bakr A, Rabie AB, Al-Kalaly A. Does the degree of advancement during functional appliance therapy matter? Eur J Orthod. 2008;30(3):274-82.
8. Hägg U, Rabie AB, Bendeus M, Wong RW, Wey MC, Du X, et al. Condylar growth and mandibular positioning with stepwise vs maximum advancement. Am J Orthod.
9. Larry C F L, Ricky W K W. Management of severe Class II malocclusion with sequential removable functional and orthodontic appliances: A case for MOrthRCSEd examination Dental Press J Orthod 46.e1 2011 Sept-Oct;16(5):46e.1-11.
10.Shen G, Hagg U, Darendeliler M. Skeletal effects of bite jumping therapy on the mandible— removable vs. fixed functional appliances. Orthod Craniofac Res 2005;8:2-10.
11. Patel HP, Moseley HC, Noar JH. Cephalometric determinants of successful functional appliance therapy. Angle Orthod. 2002;72: 410-17.
Copyright © 2013 Mathew T. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Research article:- Pediatrics
Basavaraj M Patil1*, Sandeep V H2, Harish G3, Venaktesh M Patil4 & Vijayanath.V5
1Associate professor,2Assistant professor,3Resident, Dept of pediatrics, M R medical college, Gulbarga, Karnataka,India.
4Associate Professor, Department of Pharmacology, Navodaya Medical College, Raichur, Karnataka,India.
5Associate Professor, Department of Forensic Medicine & Toxicology, VMKV Medical College & Hospital,Salem, Tamil Nadu,India.
Abstract:- In the present generation it has been established that newborns exposed to mother’s HIV infection have a higher mortality rate than those not exposed. At the same time, some authors have shown that prematurity and low birth weight were considerably associated to morbidity and mortality in the neonatal period as well as in the first year of life. In the present study, 50 HIV seropositive women delivered newborns were considered and followed prospectively and studied the consequences of neonatal outcome in HIV positive mother in terms of mortality, morbidity and somatic growth pattern. The focus of this study is to know the demographic characteristics, load of HIV transmission from mother to child, increase the effectiveness of preventive aspects of HIV regarding mother to child transmission and also to know the neonatal outcome and complications associated. In the present study it was observed that 48% of the seropositive mothers were in the age group of 21 to 25 years most of them were illiterates and housewives.
Keywords:- Infection; Mother; Child; Transmission.
References:- 1.Temmerman M, Plumer FA, Mirza NB, Ndinya-Achola JO, Wamola IA, Nagelkerke N et al. Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS. 1990; 4 (11):1087-93.
2.Newell ML, Branhmbhatt H, Ghys P. Child mortality and HIV infection in Africa: a review. AIDS. 2004 Jun;18 Suppl 2:S27-34.
3.UNICEF. Les enfants et le SIDA: un désastre imminent; les repercussions croissantes de l’infection à VIH sur les femmes, les enfants et la vie familiale dans le monde en développement. Genève 1990 : 6-8.
4.Monebenimp F, Thio R, Nana AD. Morbidité et mortalité des naissances intra hospitalières du CHU de Yaoundé, Cameroun. Clin Mother Child Health. 2005 ; 2(2) : 355-8.
5.Chase HC. Infant mortality and weight at birth: 1960 United States birth cohort. Am J Public Health Nations Health. 1969; 59: 1618-28.
6.Taha TE, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR et al. The effect of human immunodeficiency infection on birth weight and infant and child mortality in urban Malawi. Int J Epidemiol. 1995; 24(5): 1022-9.
7.Braddick MR, Keiss JK, Embree JB et al. Impact of maternal HIV infection on obstetrical and early pregnancy outcome. AIDS, 1990, 4:1001-5.
8.Turner et al. Prenatal Care & Birth Outcome of a cohort of HIV-infected women. Journal of AIDS & Human Retrovirology. 1996 Jul; 12(3):259-67.
9.Stratton el al. (1989-1994) Obstetric K& Newborn Outcomes in a cohort of HIV- infected pregnant women: A Report of the women & Infants Transmission study. Journal of Acquired Immune Deficiency syndromes & I Iuman Retrovirology. 1999 Feb 1 ;20(2): 179-86.
10.Goldstein PJ, Smit R, Stevens M, Sever JL. Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants. Infect Dis Obstet Gynecol 2000; 8: 94-8.
11.Martin et al. Incidence of Premature birth & Neonatal respiratory disease in infants of HIV-positive mothers. Journal of Pediatrics. 1997 Dec; 131 (6):851 -6.
12.Dreyfuss ML, Msamanga GI, Spiegelman D, et al. Determinants of low birth weight among HIVinfected pregnant women in Tanzania. Am J Clin Nutr 2001; 74: 814-26.
13.Minkoff H, Nanda D, Menez R, Fikrig S. Pregnancies resulting in infants with acquired immune deficiency syndrome or AIDS related complex. Obstet Gynecol, 1987, 69:285.
14.Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. British Journal of Obstetrics and Gynaecology, 1998, 105:839-48.
15.RW Ryder, W Nsa, SE Hassig, F Behetset al: Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive woman in Zaire: New England Journal of Medicine Volume 320:1637-42.
16.K. K. Jain, R. K. Mahajan, M. Shevkani and P. Kumar, “Early Infant Diagnosis: A New Tool of HIV Diagnosis in Children,” Journal of Community Medicine 36(2); 2011: 139-42 .
17. Rosemary Spira, Philippe Lepage, Philippe Msellati et al: Natural History of Human Immunodefiency Virus Type 1 Infection in Children: A Five-Year Prospective Study in Rwanda: Journal of American Academy of Pediatrics 104 No. 5 November 1999, p. e56.
18.Miriam Adhikari, Shuaib Kauchali and Anitha Moodley: Clinical Profile and Morbidity Pattern of Infants Born to HIV Infected Mothers in Durban South Africa: Indian Pediatrics 2006;43:804-8.
19.Minkoff H, Nanda D, Menez R, Fikrig S. Pregnancies resulting in infants with acquired immune deficiency syndrome or AIDS related complex. Obstet Gynecol, 1987, 69:285.
20.Dreyfuss ML, Msamanga GI, Spiegelman D, et al. Determinants of low birth weight among HIVinfected pregnant women in Tanzania. Am J Clin Nutr 2001; 74: 814-26.
Copyright © 2013 Basavaraj M Patil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Letter to editor
Dr. Ruby Khan
Associate Professor, Department of Periodontology & implantology, Institute of Dental Sciences, Bareilly, UP, India.
*Correspondence address:
Dr. Ruby Khan,
Associate Professor,
Department of Periodontology & Implantology,
Institute of Dental Sciences, Bareilly, U.P., India.
Research article:- Anesthesia
Ansari Mohammad U1, Porwal Sanjay K2*, Garg Ganga S1, Swarnkar Madhusudan3, Qureshi Salim4 & Lodha Lakhapat R5
1Assistant Professor,5Senior Professor, Department of Anesthesia,2Associate Professor, Department of Surgery ,3Assistant Professor, Department of P.S.M,4Medical Officer Jhalawar Hospital and Medical College Society, Jhalawar (Raj.) India.
Abstract: Background: Shivering is a common problem faced by an anesthesiologist during intra operative as well as post operative period. Shivering occurs during both general anaesthesia and regional anaesthesia but it is more troublesome during neuraxial anaesthesia. Neuraxial anaesthesia impairs thermoregulatory control and upto 40-60% incidence of shivering has been reported. Aim: To evaluate the effectiveness of intravenous ketamine and tramadol in control of shivering and to note the side effects of drug used. Methods: This study was conducted in 60 ASA I and II patients. Neuraxial anaesthesia was performed with 3.0 ml (15 mg) of 0.5% of Bupivacaine heavy in all patients The patients were allocated in two groups of 30 each to receive ketamine 0.5 mg/kg (group K) and tramadol 0.5 mg/kg (group T) i. v. after the appearance of shivering. Disappearance and recurrence of shivering as well as temperature and haemodynamics were recorded with scheduled intervals. Shivering was graded from 0-4 grades and recurrence of shivering if occurred than additional dose of either ketamine or tramadol 0.5 mg/kg was given in respective group. Results: Onset of disappearance of shivering was found at 01 minute in tramadol group (T) P<0.05 and 3 minutes in ketamine group (K) <0.05. The complete disappearance of shivering took 5 minutes in T group and 8 minutes in K group. Recurrence rate of shivering was 10% in T and 20% in K group of patients respectively. None of the patients has any complication except nausea and vomiting (6.66% and 3.33% in group T and K respectively P<0.05). Conclusion: Thus tramadol and ketamine were equally efficacious, but tramadol was more potent with respect to control of shivering and its recurrence. It was concluded that i.v. tramadol is qualitatively superior to ketamine for control of shivering.
Keywords:- Shivering, Tramadol, Ketamine, Neuraxial anaesthesia.
References:-
1.De Whitte, Sessier Dl., et al. Perioperative shivering; physiology and pharmacology. Anaesthesiology 2002; 96-467-84.
2.Sessler Dl., Ponrw J. Shivering during epidural anesthesia. Anaesthesiology 1990; 72:816-21.
3.Sessler Dl., Perioperative heat balance, Anaesthesiology 2000;92:578-96.
4.Imrie MM, Hall GM. Body temperature and anaesthesia. BR J Anaesth 1990;64:346-54.
5.Mathews S, Al Mulla A et al. Postanesthetic shivering a new look at Tramadol. Anaesthesia 2002;57:38-403.
6.Anne Miu Han Chan, Kwok Fu et al. Control of shivering under regional anaesthesia in obstetric patients with Tramadol. Can J Anesth 1999;46(3):253-58.
7.Pascal A. Postanesthetic Shivering; Epidemiology, Pathophysiology and approaches to prevention and Management. Drugs 2001;61:2193-205.
8.Kranke P, Eberhart LH, Roewer N, Tramer MR. Single dose parenteral pharmacology interventions for the prevention of postoperative shivering: A Quantitative Systematic Reviews of Randomized Controlled Trials. Anesth Analg 2004;99:718-27.
9.Kim MS, Kim DW, Woo Sh, Yon JH, Lee S. Effect of ramosetron on shivering during neuraxial anesthesia, Korean J Anesthesiol 2010;58:256-9.
10.Gozdemir M, Usta B, Demircioglu RI, Muslu B, Sert H, Karatas OF. Magnesium sulfate infustion prevents shivering during transurethral porstatectomy with spinal anesthesia: A randomized, double blinded, controlled study, J Clin Anesth 2010;22:184-9.
11.Tsai YC, Chu KS. A comparisons, amitriptyline and meperidine for post epidural anesthetic shivering. Anesth Analg 2001; 93:1288-92.
12.Wilson E, David A, Mackenzie N, Grant IS. Sedation during spinal anaesthesia: Comparision of propofol and midazolam. Br J Anaesth 1990;64:48-52.
13.Eberhart L.H, Roewer N et al. Pharmacological treatment of postoperative shivering: a quantitative systemic review of randomized controlled trials. Anesth Anagl 2002;94(2):453-60.
14.Chaturvedi S, Domkondwar G. Control of shivering under regional anaesthesia using Tramadol. Asian Archives of Anaesthesiology and Resuscitation 2002; 52:491-6.
15.Wrench J Cavill et al. Comparision between Alfentanil, Pethidine, and placebo in the treatment of postoperative shivering. Br J Anaesth. 1997; 79:541-42.
16.Takehiko I, Sessler Daniel I et al. Mepridine and Alfentanyl do not reduce the gain or maximum intensity of shivering. Anaesthesiology 1998;88(4)858-65.
17.Iawashita H, Matsukawa T, Ozaki M, Seller DI, Imamura M, Kumazawa T. Hypoxemia decreases the shivering threshold in rabbits anesthesized with 0.2 MAC isoflurane, Anesth Analg 1998;87:1408-11.
18.Powell RM, Buggy DJ. Ondansetron given before induction of anesthesia reduce shivering after general anesthesia, Anesth Analg 2000;90:1423-7.
19.Ikeda T, Kazama T, Sessler DI, Toriyama S, Niwa K, Shimada C, et al. Induction of anesthesia with ketamine reduces the magnitude of redistribution hpothermai. Anesth Analg 2001;93:934-8.
20.Write J De Deloof, T et al. Tramadol in the treatment of post anesthetic shivering. Acta Anaesthesiol Scnad 1997;41:506-10.
21.Sia S. I.v. clonidine prevents post extradural shivering. Br J Anaesth 1998;81:145-6.
22.Bhatnagar S, Saxena A, Kannan TR, Punj J. Panigrahi M. Mishra S. Tramadol for postoperative shivering: A double blind comparison with pethidine. Anaesth Intensive Care 2001; 29:149-54.
23.Wason R. Jain N. Gupta P, Gogia AR, Randomized double blind comparison of prophylactic ketamine, clonidine and tramadol for the control of shivering under neuraxial anaesthesia. Indian J Anaesht 2012;56:370-5.
24.Sagir O, Gulhas N, Toprak H, Yucel A, Begec Z, Ersoy O. Control of shivering during regional anaesthesia: Prophylactic ketamine and granisetron. Acta Anaesthesiol Scand 2007;51:44-9.
25.Dal D, Kose A, Honca M, Akinci SB, Basgul E, Aypar U. Efficacy of prophylactic ketamine in preventing postoperative shivering. Br J Anaesth 2005;95:189-92.
26.Gangopadhyay S, Gupta K, Acharjee S, Nayak SK, Dawn S, Pipal G. Ketamine, tramadol and pethidine in prophylaxis of shivering during spinal anaesthesia. J Anaesthesiol Clin Pharmacol 2010;56:59-63.
27.Bilotta E Pietropaoli P, Sanita R, Liberatori G, Rosa G. Nefopam and tramadol for the prevention of shivering during neuraxial anesthesia. Reg Anesth Pain Med 2002; 27:380-4.
28.Chan AM. Ng KE Tong EW, Jan GS. Control of shivering under regional anaesthesia in obstetric patients with tramadol. Can J Anaesth 1999; 46:253-8.
29.Tewari A, Katyal S, Singh A, Garg S, Kaul TK, Narula N. Prophylaxis with oral clonidine prevents perioperative shivering in patients undergoing transurethral resection of prostate under subarachnoid block. Indian J Urol 2006;22:208-12.
30.Nishiyama T, Yokoyama T, Hanaoka K. Sedation guidelines for midazolam infusion during combined spinal and epidural anesthesia. J Clin Anesth 2004;16:568-22.
Copyright © 2013 Porwal Sanjay K et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Literature review:-Periodontics,
Mitul Kumar Mishra1* & Shilpi Tiwari2
1Assistant professor, Department of Periodontics, Swargiya Dadasaheb Kalmegh Smruti Dental College and Hospital, Nagpur, India.
2Assistant professor, Department of Pedodontics and preventive dentistry, Peoples College of dental sciences, Bhopal, India.
Abstract:- With the growing interest in self-care and integrative medicine coupled with our health embracing baby boomer population, recognition of the link between diet and health has never been stronger. As a result, the market for functional foods, or foods that promote health beyond providing basic nutrition, is flourishing. Within the functional foods movement is the small but rapidly expanding arena of probiotics–live microbial food supplements that beneficially affect an individual by improving intestinal microbial balance. By definition, probiotics are live microorganisms that when administered in adequate amounts confer health benefits upon the host. Based on current research data the effects of probiotics on periodontal health and its maintenance are not clear. Systematic in vitro studies are first needed to learn more about the eventual interactions of probiotic species and periodontal pathogens and oral biofilms, and also about their effects on periodontal host tissue reactions. Key words:- Periodontal health, probiotics, biofilm.
References:-
1.Saito T. Selection of useful probiotic lactic acid bacteria from the Lactobacillus acidophilus group and their applications to functional foods. Anim Sci J 2004: 75:1–13.
2.Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 2005: 113: 188–96.
3.Hojo K, Mizoguchi C, Takemoto N, Oshima T, Gomi K, Arai T, Maeda N. Distribution of salivary lactobacillus and bifidobacterium species in periodontal health and disease. Biosci Biotechnol Biochem 2007: 71: 152–7.
4.Socransky S, Haffajee A. Periodontal microbial ecology. Periodontol 2000 2005: 38: 135–87.
5.Stamatova I, Kari K, Meurman JH. In vitro evaluation of antimicrobial activity of putative probiotic lactobacilli against oral pathogens. Int J Probiotics Prebiotics 2008: 2:225–232.
6.Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006: 30:55–60.
7.Haukioja A, Yli-Knuuttila H, Loimaranta V, Kari K, Ouwehand AC, Meurman JH, Tenovuo J. Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Microbiol Immunol 2006: 21: 326–32.
8.Collado MC, Surono I, Meriluoto J, Salminen S. Indigenous dadih lactic acid bacteria: cell-surface properties and interactions with pathogens. J Food Sci 2007: 72: M89–M93.
9.Haukioja A, Loimaranta V, Tenovuo J. Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro. Oral Microbiol Immunol 2008: 23: 336– 43.
10.Ko˜ll-Klais P, Ma¨ndar R, Leibur E, Marcotte H, Hammarstrom L, Mikelsaar M. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 2005: 20: 354–61.
11.Marcotte H, Ko˜ll-Klais P, Hultberg A, Zhao Y, Gmur R, Mandar R, Mikelsaar M, Hammarstro¨m L. Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus. J Appl Microbiol 2005: 100: 256–63.
12.Teughels W, Newman MG, Coucke W, Haffajee A, Van Der Mei HC, Haake SK, Schepers E, Cassiman JJ, Van Eldere J, van Steenberghe D, Quirynen M. Guiding periodontal pocket recolonization: a proof of concept. J Dent Res 2007: 86: 1078–82.
13.Grajek W, Olejnik A, Sip A. Probiotics, prebiotics and antioxidants as functional foods. Acta Biochim Pol 2005; 52:665–71.
Copyright © 2013 Mitul K Mishra & Shilpi Tiwari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.